Obesity in psoriasis: Leptin and resistin as mediators of cutaneous inflammation

British Journal of Dermatology

Volumn 159, Issue 2, 2008, Pages 342-350

  Johnston, A ^a   Arnadottir, S ^b   Gudjonsson, J E ^c   Aphale, A ^c   Sigmarsdottir, A A ^b   Gunnarsson, S I ^b   Steinsson, J T ^d   Elder, J T ^c,e   Valdimarsson, H ^a,b  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b UNIVERSITY OF ICELAND   (Iceland)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d Blue Lagoon Dermatological Clinic   (Iceland)

^e VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

Cytokines; Leptin; Obesity; Psoriasis; Resistin; UVB

Indexed keywords

ADIPOCYTOKINE; AMPHIREGULIN; CXCL9 CHEMOKINE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; LEPTIN RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; RESISTIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE SEVERITY; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INFLAMMATORY INFILTRATE; MALE; MEDIATOR; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; PSORIASIS; QUANTITATIVE ANALYSIS; RADIATION EXPOSURE; SKIN INFLAMMATION; ULTRAVIOLET B RADIATION; WAIST CIRCUMFERENCE;

ADIPOKINES; ADULT; AGED; AGED, 80 AND OVER; BODY CONSTITUTION; BODY MASS INDEX; CHRONIC DISEASE; CYTOKINES; DOWN-REGULATION; FEMALE; GLYCOPROTEINS; HUMANS; INFLAMMATION MEDIATORS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; MALE; MIDDLE AGED; OBESITY; PSORIASIS; RECEPTORS, LEPTIN; RESISTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; SKIN; TISSUE CULTURE TECHNIQUES; ULTRAVIOLET THERAPY;

EID: 47549113861     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08655.x     Document Type: Article

References (56)

1. Christophers E. Psoriasis - epidemiology and clinical spectrum. Clin Exp Dermatol 2001 26 : 314 20.
2. Griffiths CE, Christophers E, Barker JN et al. A classification of psoriasis vulgaris according to phenotype. Br J Dermatol 2007 156 : 258 62.
3. Valdimarsson H. The genetic basis of psoriasis. Clin Dermatol 2007 23 : 563 7.
4. Nair RP, Stuart PE, Nistor I et al. Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am J Hum Genet 2006 78 : 827 51.
5. Valdimarsson H, Baker BS, Jonsdottir I et al. Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol Today 1995 16 : 145 9.
6. Telfer NR, Chalmers RJ, Whale K et al. The role of streptococcal infection in the initiation of guttate psoriasis. Arch Dermatol 1992 128 : 39 42.
7. Gudjonsson JE, Thorarinsson AM, Sigurgeirsson B et al. Streptococcal throat infections and exacerbation of chronic plaque psoriasis: a prospective study. Br J Dermatol 2003 149 : 530 4.
8. Naldi L, Chatenoud L, Linder D et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol 2005 125 : 61 7.
9. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 1995 32 : 982 6.
10. Raychaudhuri SP, Gross J. Psoriasis risk factors: role of lifestyle practices. Cutis 2000 66 : 348 52.
11. Marino MG, Carboni I, De Felice C et al. Risk factors for psoriasis: a retrospective study on 501 outpatients clinical records. Ann Ig 2004 16 : 753 8.
12. Neimann AL, Shin DB, Wang X et al. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006 55 : 829 35.
13. Sommer DM, Jenisch S, Suchan M et al. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006 298 : 321 8.
14. Rucevic I, Perl A, Barisic-Drusko V et al. The role of the low energy diet in psoriasis vulgaris treatment. Coll Antropol 2003 27 : 41 8.
15. Higa-Sansone G, Szomstein S, Soto F et al. Psoriasis remission after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes Surg 2004 14 : 1132 4.
16. Herron MD, Hinckley M, Hoffman MS et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 2005 141 : 1527 34.
17. Sterry W, Strober BE, Menter A. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. Br J Dermatol 2007 157 : 649 55.
18. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000 11 : 327 32.
19. Curat CA, Wegner V, Sengenes C et al. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006 49 : 744 7.
20. Kanda H, Tateya S, Tamori Y et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006 116 : 1494 505.
21. Fain JN, Madan AK, Hiler ML et al. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004 145 : 2273 82.
22. Bruun JM, Lihn AS, Madan AK et al. Higher production of IL-8 in visceral vs. subcutaneous adipose tissue. Implication of nonadipose cells in adipose tissue. Am J Physiol Endocrinol Metab 2004 286 : E8 13.
23. Gearing AJ, Fincham NJ, Bird CR et al. Cytokines in skin lesions of psoriasis. Cytokine 1990 2 : 68 75.
24. Bonifati C, Carducci M, Cordiali Fei P et al. Correlated increases of tumour necrosis factor-alpha, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients - relationships with disease severity. Clin Exp Dermatol 1994 19 : 383 7.
25. Gudjonsson JE, Johnston A, Sigmundsdottir H et al. Immunopathogenic mechanisms in psoriasis. Clin Exp Immunol 2004 135 : 1 8.
26. Muoio DM, Lynis Dohm G. Peripheral metabolic actions of leptin. Best Pract Res Clin Endocrinol Metab 2002 16 : 653 66.
27. Pelleymounter MA, Cullen MJ, Baker MB et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995 269 : 540 3.
28. Lord GM, Matarese G, Howard JK et al. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998 394 : 897 901.
29. Palacio A, Lopez M, Perez-Bravo F et al. Leptin levels are associated with immune response in malnourished infants. J Clin Endocrinol Metab 2002 87 : 3040 6.
30. Farooqi IS, Matarese G, Lord GM et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 2002 110 : 1093 103.
31. Ferraroni NR, Geloneze B, Mansour E et al. Severe hypoleptinaemia associated with insulin resistance in patients with common variable immunodeficiency. Clin Endocrinol (Oxf) 2005 63 : 63 5.
32. Goldberg AC, Eliaschewitz FG, Montor WR et al. Exogenous leptin restores in vitro T cell proliferation and cytokine synthesis in patients with common variable immunodeficiency syndrome. Clin Immunol 2005 114 : 147 53.
33. Matarese G, Di Giacomo A, Sanna V et al. Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol 2001 166 : 5909 16.
34. De Rosa V, Procaccini C, Cali G et al. A key role of leptin in the control of regulatory T cell proliferation. Immunity 2007 26 : 241 55.
35. Loffreda S, Yang SQ, Lin HZ et al. Leptin regulates proinflammatory immune responses. FASEB J 1998 12 : 57 65.
36. Zarkesh-Esfahani H, Pockley G, Metcalfe RA et al. High-dose leptin activates human leukocytes via receptor expression on monocytes. J Immunol 2001 167 : 4593 9.
37. Mattioli B, Straface E, Quaranta MG et al. Leptin promotes differentiation and survival of human dendritic cells and licenses them for Th1 priming. J Immunol 2005 174 : 6820 8.
38. Steppan CM, Bailey ST, Bhat S et al. The hormone resistin links obesity to diabetes. Nature 2001 409 : 307 12.
39. Nagaev I, Smith U. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun 2001 285 : 561 4.
40. Savage DB, Sewter CP, Klenk ES et al. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 2001 50 : 2199 202.
41. Utzschneider KM, Carr DB, Tong J et al. Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans. Diabetologia 2005 48 : 2330 3.
42. Kaser S, Kaser A, Sandhofer A et al. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun 2003 309 : 286 90.
43. Bokarewa M, Nagaev I, Dahlberg L et al. Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005 174 : 5789 95.
44. Patel L, Buckels AC, Kinghorn IJ et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 2003 300 : 472 6.
45. Lehrke M, Reilly MP, Millington SC et al. An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med 2004 1 : e45.
46. Silswal N, Singh AK, Aruna B et al. Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem Biophys Res Commun 2005 334 : 1092 101.
47. Fredriksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978 157 : 238 44.
48. Corbetta S, Angioni R, Cattaneo A et al. Effects of retinoid therapy on insulin sensitivity, lipid profile and circulating adipocytokines. Eur J Endocrinol 2006 154 : 83 6.
49. Boehncke S, Thaci D, Beschmann H et al. Psoriasis patients show signs of insulin resistance. Br J Dermatol 2007 157 : 1249 51.
50. Verma S, Li SH, Wang CH et al. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 2003 108 : 736 40.
51. Mu H, Ohashi R, Yan S et al. Adipokine resistin promotes in vitro angiogenesis of human endothelial cells. Cardiovasc Res 2006 70 : 146 57.
52. Cook PW, Mattox PA, Keeble WW et al. A heparin sulfate-regulated human keratinocyte autocrine factor is similar or identical to amphiregulin. Mol Cell Biol 1991 11 : 2547 57.
53. Zheng Y, Danilenko DM, Valdez P et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007 445 : 648 51.
54. Stallmeyer B, Kampfer H, Podda M et al. A novel keratinocyte mitogen: regulation of leptin and its functional receptor in skin repair. J Invest Dermatol 2001 117 : 98 105.
55. Frank S, Stallmeyer B, Kampfer H et al. Leptin enhances wound re-epithelialization and constitutes a direct function of leptin in skin repair. J Clin Invest 2000 106 : 501 9.
56. Rennekampff HO, Hansbrough JF, Kiessig V et al. Bioactive interleukin-8 is expressed in wounds and enhances wound healing. J Surg Res 2000 93 : 41 54.